89-104-471

FABP3, Mouse, Polyclonal Antibody, Abnova™

Manufacturer: Abnova Corporation

Select a Size

Pack Size SKU Availability Price
Each of 1 89-104-471-Each-of-1 In Stock ₹ 30,794.00

89-104-471 - Each of 1

₹ 30,794.00

In Stock

Quantity

1

Base Price: ₹ 30,794.00

GST (18%): ₹ 5,542.92

Total Price: ₹ 36,336.92

Antigen

FABP3

Classification

Polyclonal

Description

Mouse polyclonal antibody raised against a full-length recombinant FABP3.

Gene

FABP3

Gene Alias

FABP11/H-FABP/MDGI/O-FABP

Host Species

Mouse

Quantity

50 μL

Primary or Secondary

Primary

Target Species

Human

Form

Antisera

Applications

ELISA, Western Blot

Conjugate

Unconjugated

Formulation

50% glycerol

Gene Accession No.

BC007021

Gene Symbols

FABP3

Immunogen

FABP3 (AAH07021, 1 a.a. to 133 a.a) full-length recombinant protein with GST tag.

Regulatory Status

RUO

Gene ID (Entrez)

2170

Content And Storage

Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.

Related Products

Img

Abnova Corporation

89-104-469

--

Img

Abnova Corporation

89-104-101

--

Img

Abnova Corporation

89-104-182

--

Img

Abnova Corporation

89-104-541

--

Img

Abnova Corporation

89-104-389

--

Img

Abnova Corporation

89-104-508

--

Img

Abnova Corporation

89-104-609

--

Img

Abnova Corporation

89-104-807

--

Description

  • The intracellular fatty acid-binding proteins (FABPs) belongs to a multigene family
  • FABPs are divided into at least three distinct types, namely the hepatic-, intestinal- and cardiac-type
  • They form 14-15kDa proteins and are thought to participate in the uptake, intracellular metabolism and/or transport of long-chain fatty acids
  • They may also be responsible in the modulation of cell growth and proliferation
  • Fatty acid-binding protein 3 gene contains four exons and its function is to arrest growth of mammary epithelial cells
  • This gene is a candidate tumor suppressor gene for human breast cancer
  • [provided by RefSeq Sequence: MVDAFLGTWKLVDSKNFDDYMKSLGVGFATRQVASMTKPTTIIEKNGDILTLRTHSTFKNTEISFKLGVEFDETTADDRKVKSIVTLDGGKLVHLQKWDGQETTLVRELIDGKLILTLTHGTAVCTRTYEKEA